Janssen Submits EU Marketing Application for VELCADE (bortezomib) in Mantle Cell Lymphoma

30-06-2014 Business Wire HealthComments (0)

JanssenPharmaceuticalVelcade

JANSSEN SUBMITS EU MARKETING APPLICATION FOR VELCADE (BORTEZOMIB) IN MANTLE CELL LYMPHOMA

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top